PP_1170x120_10-25-21

Retin-A

Perrigo closes Retin-A acquisition

Perrigo closes Retin-A acquisition

DUBLIN, Ireland — Perrigo Co. plc has completed its acquisition of a portfolio of generic dosage forms and strengths of acne topical treatment Retin-A from Matawan Pharmaceuticals LLC. Financial terms of deal, announced in mid-December, weren’t disclosed. Perrigo was the authorized generic distributor of these Retin-A (tretinoin) products from 2005 to 2013 before the agreement

Adheris Health